About The Antibody
Series
The Antibody Series: The Global Reference for Antibody Innovation
The Antibody Series is recognized as the worldwide reference event for antibody discovery and development, setting the benchmark for scientific excellence and innovation. More than just a conference, it is an exclusive, invitation-only gathering where top-tier experts from Industry, Academia, and Venture Capital come together to shape the future of therapeutic antibodies.
With an exquisite and carefully curated program, The Antibody Series offers an unmatched platform for deep scientific exchange, showcasing the most disruptive technologies and breakthrough innovations that are redefining the landscape of antibody engineering, development, and translational science.
Unlike large-scale generalist events, The Antibody Series provides an intimate, high-level environment designed to foster strategic collaboration, ignite game-changing ideas, and facilitate meaningful networking among the true pioneers of the field. Every session is built to challenge conventions, spark forward-thinking discussions, and drive tangible progress.
From AI-powered discovery platforms to next-generation modalities, antibody-drug conjugates, and cutting-edge immunotherapies, The Antibody Series is where science meets technology, and where the future of antibodies is defined.
This is not a typical conference. This is where leaders come together to innovate, collaborate, and inspire.
6
innovative antibody sessions
+16
talks from experts in industry and academia
+4,300
attendees since 2021
2026 Speakers
Co-founder and Executive Vice President of Technology and Scientific Office at FairJourney Bio
Mark Cragg is Professor of Experimental Cancer Biology in the School of Cancer Sciences at the Unive
Dr. Robert A. Seder is currently Acting Associate Director and Chief of the Cellular Immunology Sect
Associate Professor (since 2018) at ETH Zurich in the Department of Biosystems Science and Engineeri
What Delegates Are Saying
"The organizers of The Antibody Series always manage to invite great speakers which results in highly interesting and relevant presentations. In addition the meeting always attracts the best and brightest in antibody research as attendees and gets them all together in a very pleasant and informal setting so this is by far the best event for networking. Highly recommendable!"
"We at INFORS HT greatly value our long-standing partnership with The Antibody Series and FairJourney Biologics. The event offers an outstanding platform to connect with leading scientists and innovators in antibody discovery and development. Its consistently high-quality content and collaborative atmosphere reflect the values we share as a company. That’s why we are proud to support the event again this year."
"The Antibody Series is Europe’s premier conference and networking hub for leaders in antibody discovery and development—hosted by FairJourney, the continent’s most dynamic and forward-thinking antibody CRO.”
"Innovation relies not just on sharing scientific data, but connecting people, evolving ideas and being inspired to do something remarkable. The Antibody Series goes from strength to strength each year in providing these special ingredients to enable the antibody community.""
"A wonderful event combining superb presentations, excellent networking opportunities and festivities"